Abstract
With the development of the machine-learning field, the early detection of diseases and development of new drugs are being conducted by learning vast amounts of medical data. The authors theoretically analyze medical-data holders’ provision decision from the perspective of a public-goods model. Through a meta-analysis of medical datasets on paperswithcode.com, the authors explore the relationship between medical-data sample size and machine-learning models’ scores using such data. The result suggests that an increase in the number of data providers leads to higher model performance, depending on the score measurement selected.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have